NCT05308732 2026-01-08
Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy
Instituto Nacional de Cancer, Brazil
Phase 1 Active not recruiting
Clinical Trials
12 trialsNCT06446180 2025-06-25
Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy
The General Hospital of Western Theater Command
Phase 1 Completed
NCT06669390 2024-11-01
A Mouthwash Medicine for the Reduction or Prevention of Mouth Ulceration Caused by Radiotherapy for Head and Neck Cancer
VasoDynamics Ltd
Phase 1 Completed
NCT03399331 2024-08-07
Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy
American University of Beirut Medical Center
Phase 1 Completed
NCT06044142 2024-08-05
Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment
Riyadh Elm University
Phase 1 Completed
NCT01668849 2022-08-09
Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer
University of Louisville
Phase 1 Completed
NCT02531906 2022-07-25
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
Roswell Park Cancer Institute
Phase 1 Completed
NCT01092975 2020-12-28
Safety of Phenylephrine for Oral Mucositis Prevention
University of Wisconsin, Madison
Phase 1 Terminated
NCT01921426 2016-09-22
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Galera Therapeutics, Inc.
Phase 1 Completed
NCT00460421 2014-12-05
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
Swedish Orphan Biovitrum
Phase 1 Completed
NCT00938080 2014-01-07
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck
ActoGeniX N.V.
Phase 1 Completed
NCT00584597 2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1 Completed